Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409809 · ClinicalTrials.gov registry record · NA
Implementation Support for Prevention Program Delivery by College Peer Educators
A NA study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,261
- Enrollment target
NCT03409809: Completed NA study, sponsored by Oregon Research Institute.
NCT03409809 is a NA study that has completed, run by Oregon Research Institute. The registered enrollment target is 2,261 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03409809, a NA study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,261 participants
- Enrollment target
Study Summary
This project will evaluate 3 approaches of implementation support for university peer leaders who will deliver a prevention program with a particularly strong evidence-base compared to changes observed in outcomes in response to usual care at the universities before implementation. This study aims to advance knowledge of this innovative and economical way to provide college prevention programs to reduce the burden of mental illness in the college student population.
Primary Outcome
Peer educators' adherence to scripted intervention manual and accuracy of script delivery as coded through evaluation of audio-recorded sessions by two clinicians independently coding a random selection of sessions using the Session Adherence Scale. Coders will indicate the extent to which peer leaders adhere to the 25 total total necessary components of the 4-session intervention script using a scoring guide ranging from 10 (indicating no adherence) to 100 (indicating perfect adherence) with a
Interventions
- BEHAVIORAL Training
- BEHAVIORAL Training and Technical Assistance
- BEHAVIORAL Training, Tech. Assistance, Quality Assurance/Improvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,261 participants |
| Start Date | 2018-01-15 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
What the finished NCT03409809 record still lists
NCT03409809 is an interventional study that assigns participants to a tested intervention. Its 2,261 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher).
The record links to 0 conditions, and to 3 interventions - of which Training is the first listed.
NCT03409809 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03409809 about?
NCT03409809 is a clinical study titled "Implementation Support for Prevention Program Delivery by College Peer Educators". This project will evaluate 3 approaches of implementation support for university peer leaders who will deliver a prevention program with a particularly strong evidence-base compared to changes observed in outcomes in response to usual care at the universities before implementation. This study aims t...
What is the current status of trial NCT03409809?
This trial is currently completed. It is a NA study. The enrollment target is 2,261 participants. The study started on 2018-01-15. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT03409809?
The interventions under investigation include: Training (BEHAVIORAL), Training and Technical Assistance (BEHAVIORAL), Training, Tech. Assistance, Quality Assurance/Improvement (BEHAVIORAL).
Who is sponsoring clinical trial NCT03409809?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03409809's enrollment target sits among peer trials
2,261 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI